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ABSTRACT ABF2 (ARS-binding factor 2), a small, basic
DNA-binding protein that binds specifically to the autono-
mously replicating sequence ARSI, is located primarily in the
mitochondria of the yeast Saccharomyces cerevisia.. The abun-
dance ofABF2 and the phenotype of abJ2- null mutants argue
that this protein plays a key role in the structure, maintenance,
and expression of the yeast mitochondrial genome. The pre-
dicted amino acid sequence of ABF2 Is closely related to the
high-mobility group proteins HMG1 and HMG2 from verte-
brate cell nuclei and to several other DNA-binding proteins.
Additionally, ABF2 and the other HMG-related proteins are
related to a globular domain from the heat shock protein hsp7O
family. ABF2 interacts with DNA both nonspecifically and in
a specific manner within regulatory regions, sugstng a
mechanism whereby it may aid in compacting the mitochon-
drial genome without interfering with expression.
It has been proposed that the contemporary mitochondrial
genome evolved from an ancestral endosymbiont genome
that has been pared down to include only the genes required
for oxidative phosphorylation (reviewed in refs. 1 and 2).
Replication and expression of the mitochondrial DNA
(mtDNA) are controlled by nuclear genes, but the replication
and segregation of mtDNA are independent of the corre-
sponding events in the nucleus. Although advances have
been made in understanding the general mechanism of tran-
scription and replication ofmtDNA, especially in animal cells
(3), little is known about the role of nuclear proteins in
controlling these events.
As part of a search for proteins that bind to nuclear origins
ofDNA replication in the yeast Saccharomyces cerevisiae, a
small 20-kDa protein was identified that interacted with DNA
in an unusual way (4,'5). This protein, ABF2 (ARS-binding
factor 2), bound specifically to the autonomously replicating
DNA sequence ARSJ, but also induced negative supercoiling
ofcircular plasmid DNAs in the presence ofa topoisomerase.
We have further characterized this unusual DNA-binding
protein. ABF2 contains two high-mobility group (HMG)-box
DNA-binding motifs that have been found in a number of
regulatory DNA-binding proteins. Interestingly, a substantial
fraction of this HMG-like protein localizes to the mitochon-
dria, where it is required for efficient maintenance ofmtDNA
and binds specifically to transcriptional and replication reg-
ulatory sequences.
MATERIALS AND METHODS
Strains. The parental S. cerevisiae strains used in this study
were: SP1: MATa, ura3-52, his3, trpl-289, leu2-2,113, ade8,
can), ABF2 (6); W303-1: MATa/MATa, ade2-1/ade2-1,
ura3-1/ura3-1, his3-11,15/his3-11,15, trpl-1/trpl-1, leu2-
3,112/leu2-3,112, canl-100/canl-100, ABF2/ABF2 (7);
YAM101 is W303-1 plus ABF2/abJ2:: URA3 (this study),
YAM102-YAM106 are haploid derivatives of YAM101. The
EcoRI-Bgl II fragment from plasmid YRp7 containing the
tryptophan-requiring gene TRPJ was used to replace the Bgl
II-Sty I fragment from pAMlA (see Fig. 3A). This construct
was digested with EcoRI and used to transform the diploid
strain W303-1 to tryptophan prototrophy (8). Transformants
were analyzed by DNA blot hybridization to ensure that one
copy of the ABF2 gene was replaced with TRP1. The result-
ing strain, YAM101, was used for tetrad dissection (8) onto
either yeast extract/peptone/dextrose (YPD containing glu-
cose) or yeast extract/peptone/galactose (YPG) plates as
described to generate strains YAM102-YAM106.
DNase 1 Cleavage-Inhibition Patterns (Footprinting) and
Gel Shifts. Both methods have been described (4, 5).
Immunofluorescence andDNA Sting. Logarithmic-phase
cells (108) were fixed and processed for immunofluorescence
as described (8). Total cell DNA was visualized with the
DNA-specific dye 4' ,6-diamidino-2-phenylindole (DAPI).
The antibody used to visualize ABF2 was a polyclonal
antiserum from rabbit raised against purified ABF2 protein.
Fluorescein isothiocyanate-conjugated -goat anti-rabbit im-
munoglobulin was used as the second antibody.
Cloning and Sequencing. The following sequence from the
amino terminus of purified ABF2 was determined by D.
Marshak using an Applied Biosystems 475 protein sequencer:
Lys-Ala-Ser-Lys-Arg-Thr-Gln-Leu-Arg-Asn-Glu-Leu-Ile-
Lys-Gln-Gly-Pro-Lys-Arg-Pro-Thr-Ser-Ala-His-Phe-Leu-
Tyr-Leu-Gln-Asp. The underlined protein sequences were
used to design the following two degenerate oligonucleotides:
RTCYTGYARRTAYARRAARTG and AARGCWTCW-
AARMGRAC, where R = A or G, Y = T or C, W = A or T,
and M = A or C. One hundred picomoles of each oligonu-
cleotide was used to amplify the amino terminus-encoding
region of the ABF2 gene from 2 to 15 ng of purified genomic
DNA from the yeast strain SP1. Amplification was for 25
cycles in a Perkin-Elmer thermal cycler: 1.5 min at 940C, 5
min at 450C, and 3 min at 650C. The expected 89-base-pair
(bp) fragment was obtained and excised from a preparative
polyacrylamide gel run in Tris borate/EDTA buffer. Labeled
probe was obtained by amplifying this 89-bp product with the
same oligonucleotides for 10 cycles under the same condi-
tions except that [a-32PJdTTP was included at a final con-
centration of 1.25 uM and unlabeled dTTP was omitted. This
DNA was used to probe a partial HindIII library of genomic
DNA from the yeast strain SP1 (6) cloned in the HindIll sites
of the yeast vector YEp213. In this library (a gift from S.
Cameron and M. Wigler, Cold Spring Harbor Laboratory), the
Abbreviations: DAPI, 4',6-diamidino-2-phenylindole; ARS, autono-
mously replicating sequence; HMG, high-mobility group; YPD,
yeast extract/peptone/dextrose; YPG, yeast extract/peptone/
galactose; ABF2, ARS-binding factor 2; UBF, upstream binding
factor; SRY, sex-determining region of Y chromosome; NHP6,
nonhistone chromosomal protein 6; BiP, rat immunoglobulin heavy
chain binding protein.
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average size insert is 6 kilobases (kb). Colonies (4.5 x 104) were
screened (approximately three genome equivalents) by standard
methods, and a single strong positive colony was analyzed
further. This plasmid (pAM1) contains an 11.5-kb HindIll frag-
ment insert. A 1.6-kb EcoRI fragment that
hybridized to the labeled, amplified probe was subcloned
into pUC118 (pAMlA). Deletions were generated by the method
of Henikoff (9), and the sequence was determined by the method
of Sanger et al. (10).t [See Fig. 3A for the sequence ofthe ABF2
coding sequence and some of the 5' and 3' sequences. Note that
the protein sequence originally determined contains one discrep-
ancy with the predicted sequence (amino acid 50 is tyrosine in
Fig. 3A but histidine in the originally determined protein se-
quence cited above). A greater amount of purified ABF2 was
subsequently resequenced and shown to contain a tyrosine
residue at amino acid 50.]
Subcellular Fractionation. Subcellular fractionation of late
logarithmic-phase yeast cells from 4 liters of YPG medium
was performed as described (11). Percoll gradient-purified
nuclei were obtained as described (8). Equal cell equivalents
of each fraction were resolved on SDS/17% polyacrylamide
gels, electroblotted, and probed with a 1:250 dilution of
anti-ABF2 or a 1:2500 dilution of antiserum to p32, an
integral, mitochondrial membrane protein (11), a gift from D.
Pain and G. Blobel (Rockefeller University). Antibody was
visualized by probing blots with 1251-labeled donkey antirab-
bit IgG and subsequent autoradiography.
RESULTS AND DISCUSSION
ABF2 was initially identified in crude yeast extracts because
of its unusual interactions with a yeast origin of nuclear DNA
replication, ARSJ (4, 5). ABF2 has been purified extensively
from whole-cell yeast extracts as a polypeptide of 20 kDa,
and a polyclonal antiserum to the purified protein has been
raised. Indirect immunofluorescence (Fig. 1B) revealed a
punctate, cytoplasmic staining similar to the distribution of
mtDNA (cytoplasmic DAPI staining; Fig. LA). Subcellular
fractionation (Fig. 1C) indicated that, like a known mito-
chondrial protein (p32), ABF2 was found in purified mito-
chondria, but a substantial amount of ABF2 was also found
in the nucleus. Thus, we conclude that ABF2 is a mitochon-
drial protein and probably also a nuclear protein. The nuclear
ABF2 protein that was detected by immunoblotting was not
observed by immunofluorescence, perhaps because the an-
tigen was masked under these conditions. Quantitative im-
munoblots and DNA-binding assays with crude extracts
indicate that ABF2 is an abundant protein, present at ap-
proximately 250,000 copies per cell (data not shown), or one
molecule of ABF2 for every 15 bp of mtDNA.
ABF2 exhibited several interesting DNA-binding proper-
ties. First, in cooperation with topoisomerase I, ABF2 in-
duced the negative supercoiling of relaxed, closed-circular
plasmids (ref. 5 and unpublished data), suggesting that ABF2
bound DNA by wrapping, like the prokaryotic HU protein
(12) and the eukaryotic nucleosome (13). Second, while it
bound many DNA sequences with similar affinity, it exhib-
ited specific, phased binding to certain key regulatory se-
quences. Examples of this phased binding as visualized by
DNase 1 footprinting are shown in Fig. 2. At the nuclear
origin ofreplication, ARSI, ABF2 bound at multiple, discrete
sites across domains implicated as being important for ARS
function (Fig. 2A). Footprints on other ARSs (data not
shown) indicate that phased binding is a general feature of
ABF2 binding to chromosomal replication origins, whereas
footprinting studies on other DNAs (e.g., pBR322) reveal
generalized but not phased DNA binding.
tThe sequence reported in this paper has been deposited in the
GenBank data base (accession no. M73753).
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FIG. 1. Localization ofABF2 to the mitochondria. (A) DNA staining
of nuclei and mitochondria in a wild-type strain with the dye DAPI. (B)
Localization of ABF2 to mitochondria by immunofluorescence with
anti-ABF2 antisera. (C) Subcellular localization ofABF2 protein deter-
mined by immunoblotting. Extracts from whole cells (lanes W), cytosol
(lanes C), mitochondria (lanes M), and nuclei (lanes N) were prepared,
and proteins were separated by gel electrophoresis. The ABF2 protein
(Left) or the p32 mitochondrial protein (Right) was detected by immu-
noblotting and indicated by arrows.
The mitochondrial localization of ABF2 together with its
phased binding at nuclear replication origins suggested that
binding of ABF2 at mitochondrial regulatory regions may
also be phased. REP2 is a region from the yeast mitochondrial
genome that contains a promoter for the mitochondrial RNA
polymerase and has been inferred to contain one of several
origins of mitochondrial DNA replication based on the phe-
nomenon ofhypersuppressivity (15). In addition to regions of
general, nonspecific binding, ABF2 binds strongly to a single
site immediately adjacent to the promoter where the mito-
chondrial RNA polymerase has previously been shown to
bind specifically (16) (Fig. 2B).
Reiterations of a very short sequence containing only A
and T residues derived from a region downstream from the
RNA polymerase promoter at REP2 are still capable of
replicating theirgenomes (17), suggesting that this region may
contain a minimal origin of mtDNA replication. ABF2 bind-
ing to one of these repeated sequences exhibited phasing
similar to that seen at the nuclear origin of replication, ARSI
(Fig. 2C). It is interesting that REP2 or these sequences
derived from REP2 can also function as origins of DNA
replication in the nucleus (14), suggesting that there may be
some common feature(s) to mitochondrial and nuclear rep-
lication origins that is recognized by ABF2.
To understand further both the unusual DNA-binding
activities ofABF2 and the in vivo role of this protein, we have
cloned the ABF2 gene. Amino acid sequence was obtained
from the amino terminus of the purified ABF2 protein and
used to design two degenerate oligonucleotides that were
used to amplify the corresponding region ofthe ABF2 gene by
the polymerase chain reaction from yeast genomic DNA.
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FIG. 2. Phased ABF2 DNA binding. Various amounts of purified
ABF2 were incubated with 5'-32P-end-labeled DNA and subjected to
DNase 1 footprinting. The probes used in this experiment were: the
HindIII-EcoRl fragment from pARS1.2 (4) containing nucleotides
616-927 of ARSI and labeled at the HindIII site (A), the BamHI-
EcoRI fragment from the plasmid pGEMHS4ON7 containing REP2
on a 760-bp Nde I fragment cloned into the Sma I site ofpGEM32f(-)
and labeled at the BamHI site (B), and the BamHI (partial digest) to
Sal I fragment from the plasmid p[6414 (14) labeled at the BamHI site
(C). Lanes: G+A, a G+A-specific sequence cleavage (in B and C
only); 1-5, 1 and 5, controls (0 ng of ABF2); 2, 30 ng of ABF2; 3, 60
ngofABF2; 4,90 ngofABF2. In each case, the phased ABF2 binding
sites are indicated by brackets, while general regions of unphased
protection are indicated by dotted lines. Functional elements within
these DNA sequences are shown to the right of each panel. Domains
A and B of ARS1 have been described, as has the binding of ABF1
to domain B of this sequence (4).
This amplified DNA was used as a probe to isolate a clone
containing the ABF2 gene from a yeast genomic library. The
nucleotide sequence of the ABF2 gene was determined and is
shown in Fig. 3A. The amino-terminal amino acid sequence
determined from the purified protein is underlined in the
predicted amino acid sequence of the ABF2 protein. This
sequence starts 26 amino acids downstream from the nearest
potential start codon and these first 26 amino acids provide
a good match to a mitochondrial signal sequence (1), consis-
tent with the observed intracellular localization of ABF2. We
note that, on the basis. of the predicted aminoIacid compo-
sition, abundance, and ability to supercoil DNA, ABF2
resembles the previously characterized HM protein from
yeast mitochondria (19).
The ABF2 amino acid sequence is closely related to the
vertebrate, nonhistone chromosomal high-mobility group
protein HMGl.(ref. 20; 23% identical, 38% conserved relative
to the ABF2 protein). These HMG proteins consist of three
domains; amino-terminal and central domains, which are
closely related to each other; and an acidic carboxyl-terminal
domain (21). ABF2 is composed of two domains closely
related to the amino-terminal and central domains of HMG1
and HMG2 (hereafter referred to as. HMG boxes), but does
not contain a domain related to the carboxyl-terminal acidic
domain of the HMG proteins (Fig. 3 B and C). Several other
proteins also contain HMO boxes including the human RNA
polymerase I transcription factor UBF (upstream binding
factor; ref. 22), the product of the Schizosaccharomyces
pombe mating type gene MATJ-M, (23), the S. cerevisiae
nonhistone chromosomal protein NHP6 (24), and the product
of the recently proposed candidate for the human testis-
determining gene SRY (sex-determining region ofY chromo-
some; ref. 25). ABF2 (refs. 4 and 5 and Fig. 2), UBF (26), and
HMG1 and HMG2 (27) have been shown to bind DNA while
the others are likely to bind DNA because NHP6 is found to
be associated with chromatin (28) and MAT1-Mcand SRY are
key regulatory proteins (23, 25). Since the HMG boxes
constitute virtually the entire ABF2 protein (Fig. 3C) and
deletion analysis of UBF argues that the HMG box is
involved in DNA binding (22), the HMG box appeared to be
used as a DNA-binding motif by these different proteins. It
is interesting to note that alignment of the many phased ABF2
binding sites (Fig. 2 and data not shown) or the UBF binding
sites (29) does not reveal any easily recognizable consensus
sequences, suggesting that some feature of DNA structure
other than primary nucleotide sequence may be critical for
the binding of HMG box proteins.
We also note that the HMG box exhibits weaker but
nonetheless striking similarity to an independent globular
domain found in the ATPase region of the heat shock protein
hsp70 family (30), suggesting that the HMG box may be
derived from an ancient globular domain.
One copy of the ABF2 gene was replaced with the TRPI
gene in a diploid yeast strain (W303-1), and replacement was
verified by DNA blot hybridization. After sporulation of this
strain, tetrads were dissected, plated onto complete medium
containing dextrose (glucose), and analyzed. In most cases,
all four spores were viable, generating two TRP+ and two
trp- colonies. The four strains derived from one such tetrad
were analyzed further. Protein extracts were made from each
of the four strains and assayed for ARSI-specific DNA-
binding activity. Fig. 4A demonstrates that ABF2 DNA-
binding activity was missing from the two abJ2F mutant
strains and present in the two ABF2' wild-type strains.
Furthermore, immunoblots on these same extracts probed
with antibody raised against purified ABF2 failed to detect
any 20-kDa protein in the two abf2- mutant strains, but
recognized a 20-kDa protein that comigrated in an SDS/
polyacrylamide gel with purified ABF2 in the two ABF2+
strains (Fig. 4A). Finally, the nuli mutant strains lost all
mitochondrial immunofluorescence with anti-ABF2 antibod-
ies (data not shown). Therefore, the gene that we have
isolated encodes the major, if not only, form of ABF2.
While abf2! null mutants are viable, they exhibit a phe-
notype consistent with the mitochondrial localization of
ABF2. In medium containing a fermentable carbon source
like glucose, where mitochondrial genome function is dis-
pensable, abf2- null mutants grew nearly as well as wild type
(Fig. 4C). In contrast, in media containing a nonfermentable
carbon source like glycerol, where mitochondrial genome
function is essential, this abf2- mutant was unable to grow at
all (Fig. 4C). This is not surprising, since this particular
isolate has lost most or all mtDNA as determined by staining
of whole cells with the DNA-specific dye, DAPI (data not
shown).
The loss of mtDNA occurs rapidly in ab12- strains grown
in glucose but was not the inevitable consequence of loss of
ABF2. When tetrads from the diploid heterozygous for the
abf2- null mutant were dissected directly onto plates con-
taining glycerol as the sole carbon source, abf2- strains could
grow and could be maintained indefinitely. Under these
conditions, however, abj2- strains exhibited a growth defect
on medium containing glycerol, where mitochondrial gene
expression was required (Fig. 4D), even though almost all of
the cells appeared to contain wild-type levels of mtDNA
based upon DAPI staining (data not shown). Thus, ABF2
appeared to be important for both the maintenance and the
expression of the mitochondrial genome.
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AAT TCT GGA TCT TTA CTT TGC TGA TAT AGC ACC TTT TTT CTT TTT TTT TCT TTT
GIC TTT TTT ACG AGC CAC AGA CTT TCC TCC TTT ACC CTA CTA TTC GTA GCC GTC
TTT TTT TGT TGT TTT TTT TTT TGT GAA ACA ACG TAG CAA GAA AGG GAT CCT CAT
CCA AAC TAG GAT AAA CAA GTA AAC AGA TTA ACA AAG AAG CCA ATC AAT TAC AAC
BgI
AAC AAA TAA ATG AAC AST TAC AGC CTA TTA ACT AGA TCT TTC CAC GAA TCT TCT
MET Asn Ser Tyr Ser Leu Leu Thr Arg Ser Phe His Glu Ser Ser
AAG CCT CTT TT AAT TTG GCT AGC ACC TTG TTG AAG GCT TCC AAG AGA ACG CAG
Lys Pro Leu Fte Asn Leu Ala Ser Thr Leu Leu Lys Ala Ser Lys Arg Thr Gln
CT: AGA AAT GAA T.S ATA AAA CAG GGT CTT AAA AGG CCC ACA TCT GCT TAT TTC
Leu Arg Asn Glu Leu Ile Lys Gln Gly Pro Lys Arg Pro Thr Ser Ala Tyr Phe
.-A TAT TTG CAA GAC CAC AGA AGT CAA TTC GTT AAG GAA AAT CCA ACC TTA IGT
ve eu Gin Asp HPs Arg Ser Gln Phe Val Lys Glu Asn Pro Thr Leu Arg
C-T ITT GAA ATI AGC AAG ATT GCC GGT GAA AAG TGG CAA AAT TTA GAG GCT GAT
Inc Ala G! lie Ser Lys Tle Ala Gly Glu Lys Trp Gln Asn Leu Glu Ala Asp
ATA AAS GSh AAA TAC ATT TT GAA AGA AAA AAG TTG TAT TCT GAA TAC CAA. AAG
:le lys Gin Lys Tyr I'e Ser Glu Arg Lys Lys Leu Tyr Ser Glu Tyr Gln Lys
-GI AiG AAG GAG TTT GA_ GAA AAA CTT CCT CCA AAG AAA CCA GCA GGA CCC TTC
Ala Lys Lys Glu Phe Asp Glu Lys Leu Pro Pro Lys Lys Pro Ala Gly Pro Phe
AT AAG TAT GCC AAT GAA GTT CGT TCG CAA GTT TTT GCA CAA CAT CCT GAC AAG
:le Lys Tyr Ala Asn Glu Val Arg Ser Gln Val Phe Ala Gln His Pro Asp Lys
StyI
CI IAA TTG GAT CTA ATG AAA ATT ATC GGA GAT AAA TGG CAA TCC TTG GAT CAA
Se- Gln Leu Asp Leu MET Lys !le Ile Gly Asp Lys Trp Gln Ser Leu Asp Gln
AJC ATT AAG GAC AAA TAC ATA CAA GAG TAC AAA AAA GCT ATC CAA G.AA TAT A.AT
Ser I e Lys Asp Lys Tyr Ile Gln Glu Tyr Lys Lys Ala Ile Gln Glu Tyr Asn
ITTCGC TAC CCT CTC AAC TAG ACC GCG GTA ITT TCA CAA TGT TTT TTA TIC CTT
Ala Arg Tyr Pro Leu Asn
TAT TCT TTC CGT TCC TAT CIA AAT AAA TAA ATA AAT TTA ACT TAA CCA AGC AAG
TGT GTA GTG TTT TTA TAT CCT ATG TAA GTC TTC AAA CTT TTA TTT TAT CTC TGG
TAA CCT TTA TTC GCA TAC AAC GCC AAT GAA ACA AAC CTG TAA TAA TTT TTC ATA
ITT AAC CCA TTG ATG ATA CTT ATT AAA ATA TGT AAT CAA ATC GTC ACT ATT ACG
GTI CTT TAA TAA GAT GTC CGT ACC ACC TGG ATG GAA CTT CAA ATA ACT AGA AAT
STC ATA GAC TTT GCC GTT TAT AAC GCA CCA TAA CTC GTC CTC ACC TTT ACA ATG
I-TT CTT TAC GAT TTT TCT GTT TAT TCT TAA GGG TGG CAT TAT TTT ATA AAG GGG
TAT CT
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--I _EX Y BMFIG. 3. Cloning and sequencing of__TQB2 AsABF2. (A) Sequence of the ABF2
__yzA;4 gene. (B) Alignment of HMG boxes in
ssAd several related proteins. (C) Location
D-LQE of HMG boxes within these proteins.--LQES ESearches of data banks were by the
method of Pearson and Lipman (18),
PVoQ from which the similarities between
;PK G ABF2, HMG1, HMG2, MAT1-M0,
and rat immunoglobulin heavy chain
binding protein (BiP) were deter-
'KPYIQ I mined. Similarities between ABF2
and UBF and between SRY and
NHP6 were found subsequently upon
publication of these sequences, and
the other hsp7O-related proteins were
aligned based on their homology to
BiP. Groups of amino acids consid-t-00lLL 1ered to be conserved are: Ala-Ile-
Leu-Met-Val, Tyr-Phe-Trp-His, Arg-
Lys, Glu-Asp, Asn-Gln, and Ser-Thr.
The HMG boxes in C are indicated by
hatched boxes, and acidic domains
are indicated by stippled boxes.
We suggest that the general ability of ABF2 to bind
nonspecifically to DNA by wrapping and its specific, phased
binding at key regulatory sequences allow it to compact the
yeast mitochondrial genome without interfering with efficient
gene expression and replication. The binding of ABF2 adja-
cent to the RNA polymerase promoter (Fig. 2) and the
defective growth of abJ2- null mutants on nonfermentable
carbon sources (Fig. 4 C and D) suggest that ABF2 may also
have some positive role in gene expression or replication.
The rapid loss ofmtDNA would be consistent with this, since
the maintenance of mtDNA requires mitochondrial gene
expression (31). Recently, Parisi and Clayton (32) demon-
strated that the human mitochondrial transcription factor 1
(mtTF1) is a 24-kDa protein containing two HMG boxes.
mtTF1 binds to mtDNA promoters and activates transcrip-
tion in vitro. It is therefore probable that ABF2 is the S.
cerevisiae mtTF1 protein.
The mitochondrial genotype in yeast can influence nuclear
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FIG. 4. Characterization of abJ2- strains. (A) ABF2 DNA-
binding activity in mutant and wild-type strains. (B) ABF2 protein in
mutant and wild-type strains. (C) Generation of p0 abf2- strains. (D)
The ability of abJ2 p+ mutants to utilize nonfermentable carbon
sources. Strain YAM101 was sporulated, and tetrads were dissected
onto YPD (glucose) plates. After restreaking the colonies from one
such tetrad to ensure purity, these strains were tested for their abil-
ity to grow in the absence of exogenous tryptophan. The strains
YAM102 and YAM103 were TRP', while YAM104 and YAM105
were trp-. Extracts from these four strains were made by mixing late
logarithmic-phase cells in buffer X (4) with glass beads. Each extract
(3 ,ug) was assayed for ABF2 DNA-binding activity by using the
ARSI sequences on the EcoRI-HindIII fragment from pARS1.4.1 as
a probe (4). Purified ABF2 (0.2 ,ug) was used as a control in this
experiment (A). These same extracts were probed for ABF2 protein
by using the anti-ABF2 polyclonal antiserum. Each extract (150 pug)
was subjected to electrophoresis in SDS/15% polyacrylamide gels,
electroblotted to nitrocellulose, and probed with anti-ABF2 antibod-
ies (125I-labeled protein A was used to visualize antibody binding)
(B). These strains were tested for their ability to grow on glucose
(YPD plates containing 15% glucose) or glycerol (YPG plates).
Shown for simplicity are YAM102 (abf2-) and YAM104 (ABF2+)
(C). The diploid YAM101 was sporulated again in rich sporulation
medium, and tetrads were dissected directly onto YPG plates. All
four spores routinely germinate yielding two large colonies that are
trp- and two small colonies which are TRP+. The ability of one of
these small TRP+ strains, designated YAM106, to grow on glucose
and glycerol is shown in D. Note the much smaller size of colonies
on YPG of strain YAM106 relative to strain YAM104 shown in C.
gene expression (33), and the existence of shared transcrip-
tion factors between the nucleus and mitochondria has been
proposed (34). The localization of a portion of ABF2 to the
nucleus suggests that it may play a role in coordinating
nuclear-mitochondrial interactions, perhaps directly moni-
toring the amount ofmtDNA. If, on the other hand, ABF2 has
nuclear functions other than those related to mitochondrial
function, they must either be nonessential or duplicated by
some other gene product.
Because ABF2 is so closely related to the vertebrate
HMG1 and HMG2 proteins, it is tempting to speculate that
these proteins may have a related role in the nucleus, binding
at regulatory regions, perhaps positioning nucleosomes with
their acidic tail. For example, the region of ARS) exhibiting
phased ABF2 binding (Fig. 2) is devoid ofnucleosomes in situ
and is bordered on at least one side by a precisely positioned
nucleosome (36, 37). Furthermore, the regular pattern of
nuclease sensitivity across this region is similar to that seen
with ABF2 (Fig. 2A), suggesting that ABF2 or an ABF2-like
protein may be responsible for this pattern in vivo.
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